Dear User,
We’re excited to introduce Almanak(ALMANAK) to the Phemex Spot Market! The ALMANAK / USDT trading pair will go live at 12:10 UTC on December 11, 2025. More information about the project can be found in the details below.
Almanak(ALMANAK) Listing Schedule
| Field | Value |
|---|---|
| Asset Name | Almanak(ALMANAK) |
| Trading Pair | ALMANAK / USDT |
| Trading Zone | Spot Trading |
| Trading Starts | 12:10 UTC on December 11, 2025 |
About Almanak(ALMANAK)
Almanak is an agent-centric, no-code platform that enables users to build, optimize, and deploy sophisticated quantitative trading and asset-management strategies using an institutional-grade AI Agent Swarm. The platform compresses the development cycle of advanced financial strategies from months to minutes, democratizing access to financial intelligence traditionally reserved for hedge funds.
Official Links
- Website: https://almanak.co/
- Contract Address:0xDeFA1D21c5F1cbeac00eeB54B44C7D86467cc3a3
Happy trading!
Phemex Team
Disclaimer
Cryptocurrency prices are highly susceptible to market risk and volatility. You should invest only in products you are familiar with and fully understand the associated risks. The information provided on this page is for informational purposes only and does not constitute investment advice. It is not a recommendation to buy or sell any specific digital asset or adopt any particular investment strategy. Phemex makes no claims regarding the accuracy, suitability, or validity of any information provided or any particular asset. For further information, please refer to our Terms of Use and Risk Disclosure. Please be aware that data related to the aforementioned cryptocurrency (such as its current live price) is derived from third-party sources. It is presented to you "as is" for informational purposes only, without any representation or warranty of any kind. Links to third-party sites are not under Phemex’s control. The content expressed on this page is not intended to and should not be construed as an endorsement by Phemex of the reliability or accuracy of such content. For further information, please refer to our Terms of Use and Risk Disclosure.

